HBO Kennisbank

3 Resultaten

Sorteer op:

Zocht je misschien: master?

Radiation dose to the masseter and medial pterygoid muscle in relation to trismus after chemoradiotherapy for advanced head and neck cancer

Sophie A. Kraaijenga; Olga Hamming-Vrieze; Sonja Verheijen; Emmy Lamers (Lid Lectoraat); Lisette van der Molen; Frans J. Hilgers; Michiel W. van den Brekel; Wilma D. Heemsbergen

Abstract Background: We studied the relationship between trismus (maximum interincisor opening [MIO] ≤35 mm) and the dose to the ipsilateral masseter muscle (iMM) and ipsilateral medial pterygoid muscle (iMPM). Methods: Pretreatment and post-treatment measurement of MIO at 13 weeks revealed 17% of …

2019GezondheidArtikel

De bepaling van de mm. masseter met de myoscanner 160-B

Maaske Treurniet (Begeleider); Lisanne van Trigt (Student)

Tijdens het meten met de myoscannner 160-B wordt geadviseerd om twee metingen met voorafgaan een testmeting te gebruiken voor het stellen van een bepaling.

2016GezondheidBachelor

Dose to the masseter muscle and risk of trismus after chemoradiation for advanced head & neck cancer

S Verheijen (Onderzoeker); Emmy Lamers (Lid Lectoraat)

Purpose / objective: Head and neck cancer patients treated with chemoradiation are at risk for developing trismus (reduced mouth opening). Trismus is often a persisting side-effect and difficult to manage. It impairs eating, speech and oral hygiene, affecting quality of life. Although several studies …

2015-12-01GezondheidAndersoortig materiaal

Vorige Volgende

Radiation dose to the masseter and medial pterygoid muscle in relation to trismus after chemoradiotherapy for advanced head and neck cancer

De bepaling van de mm. masseter met de myoscanner 160-B

Dose to the masseter muscle and risk of trismus after chemoradiation for advanced head & neck cancer

Over HBO Kennisbank